The largest database of trusted experimental protocols

8 protocols using macsquant flow cytometry

1

Evaluation of Radiation-Induced Apoptosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
NHEK-Ad cells (104) were plated on 6-well cell culture plates (SPL). At 80% confluence, the cells were irradiated with 10 Gy of γ-radiation using a Gammacell® 40 Exactor (Best Theratronics; Ottawa, Canada) at the Advanced Radiation Technology Institute, Korea Atomic Energy Research Institute. Cells were trypsinized, washed, and stained with Dead Cell Apoptosis Kit with Annexin V-Alexa Fluor 488 and PI (BD Bioscience; San Jose, CA, USA) and incubated for 15 min at 37 °C in the dark. Cells were analyzed by MACSQuant flow cytometry (Miltenyi Biotech; Bergisch Gladbach, Germany). TUNEL assay was also used to determine the effect of DeinoPol on radiation-induced cell apoptosis according to the manufacturer’s instructions (Promega). In brief, cells were treated with cold 4% paraformaldehyde for 30 min and 0.3% Triton X-100 was added for 5 min. The TUNEL detecting solution (terminal deoxynucleotidyl transferase and fluorescence solution) was added and allowed to stand for 60 min at 37 °C. Images were acquired using an Olympus IX3 inverted fluorescence microscope (Tokyo, Japan).
+ Open protocol
+ Expand
2

Apoptosis Induction in BMCs and Spleen Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMCs and spleen cells (3×106) were plated on 12-well culture plates with or without 50 μg/ml DeinoPol-BRD125 for 2 h followed by 2 Gy X-ray irradiation. Apoptotic cells were counted by staining with propidium iodide (PI) (Sigma-Aldrich). Briefly, cultured cells were washed once with PBS and fixed with 70% ethanol at -20°C overnight. The fixed cells were resuspended in 1 ml of PI buffer [0.5 mg/ml RNaseA (Sigma-Aldrich) and 0.1 mg/ml PI (Sigma-Aldrich) in PBS]. After incubation for 30 minutes in the dark, the PI of individual nuclei were analyzed by MACSQuant flow cytometry (Miltenyi Biotech; Bergisch Gladbach, Germany).
+ Open protocol
+ Expand
3

Hematopoiesis Rescue by DeinoPol-BRD125

Check if the same lab product or an alternative is used in the 5 most similar protocols
The effects of DeinoPol-BRD125 on hematopoiesis were studied in vivo using BM cells transplantation assay. Donor mice were intraperitoneally injected with PBS or DeinoPol-BRD125 at 36 h and 12 h before irradiation with 4 Gy, and 30 min, 24 h, and 48 h after irradiation. On day 7 after irradiation, BM cells from donor mice were harvested and 2×106 BM cells were injected into the tail veins of recipient mice, which were lethally irradiated (8 Gy) 6 h earlier. Two and four weeks after transplantation, cells in peripheral blood were counted using an automatic blood analyzer (Hemavet 950; Drew Scientific; Miami Lakes, Florida, USA), and cell populations in the spleen were analyzed by MACSQuant flow cytometry (Miltenyi Biotech).
+ Open protocol
+ Expand
4

Multiparametric Flow Cytometry of T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PE‐labeled anti‐CCR7 (4B12; BioLegend), FITC‐labeled anti‐CD4 (GK1.5; TONBO Bioscience, San Diego, CA, USA), and PE‐Cy5‐labeled anti‐CD8a (53–6.7; TONBO Biosciences) antibodies were used to stain cell‐surface molecules after blocking the Fc receptors with 2.4G2 (BD Pharmingen, Franklin Lakes, NJ, USA). In the experiment described in Fig. 2C, CD4+ T cells were fixed and permeabilized with Fixation and Intracellular Staining Permeabilization Wash Buffer (BioLegend). Fluorescence intensity was acquired by MACSQuant flow cytometry (Miltenyi Biotec, Tubingen, Germany) and analyzed by FlowJo (TOMY Digital Biology, Tokyo, Japan).
+ Open protocol
+ Expand
5

Preclinical Evaluation of CAR-T Cell Efficacy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Preclinical in vitro studies with CAR-T cells were performed for the assessment of efficacy and cytotoxic capacity. For that purpose, anti-CD19-expressing CAR-T cells and CD19-expressing RAJI cells (Burkitt’s lymphoma, CCL-86, ATCC®) were co-cultured for 24 h, 7 days, and 14 days (effector:target; 1:1, 5:1, 10:1) prior to labeling target cells including RAJI, DAUDI (ATCC® CCL-213™), and K562 (ATCC® CCL-243) cell lines with either the CellTrace™ Violet Cell Proliferation Kit (Thermo Fisher Scientific) according to the manufacturer’s instructions or α-CD19-PE (BioLegend) and α-CD19-PE.cy7 (Miltenyi) for the analysis with flow cytometry. At the end of the co-culture process, α-EGFR-FITC (Abcam) and 7-AAD (Invitrogen) were evaluated for cytotoxicity. CAR-T cell activation was determined with the upregulation of CD25 (IL2RA, IL-2 receptor alpha chain) and CD107a (marker for degranulation of lymphocytes) on CAR-T cells using α-CD3-PE, α-CD4-Viogreen, α-CD8-Vioblue, α-CD25-APC, and α-CD107a-PE.cy5.5 (Miltenyi) with MACSQuant flow cytometry (Miltenyi). After 24 h of co-culturing, supernatants from cultured cell conditions were also collected and IFNγ cytokine levels were assessed with the Human IFNγ ELISA Kit (Thermo Fisher Scientific) according to the manufacturer’s instructions. The ELISA plate was measured at 450 nm and 550 nm using a microplate reader (BMG LABTECH).
+ Open protocol
+ Expand
6

Antibody Binding Evaluation in E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
The binding capability of the four antipeptides antibodies was tested over a pks+ (E. coli Nissle 1977) and a pks− (E. coli LMG2092) strains.
About 25 µL of the bacterial suspension was mixed with 25 µL of the FITC-conjugated antibody at a final concentration of 20 µg/mL. The samples were incubated for 15 min at RT and were then washed with FC buffer at 13,000 rpm for 5 min. Finally, bacteria were resuspended in 150 µL of FC buffer and samples were acquired using a MACSQuant Flow Cytometry (Miltenyi Biotec, Germany). Bacteria were labeled and analyzed at a different optical density (i.e., OD600=0.3, 0.6, 1, and 1.5) and with a different medium (i.e., LB, Nutrient Broth, and Nutrient Broth supplemented with 2% of glucose).
+ Open protocol
+ Expand
7

Dornase alfa and MgSO4 Effects on PBMC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Three healthy adult blood was obtained from Acibadem Labcell Cellular Therapy Laboratory.
Following the isolation of peripheral mononuclear cells (PBMC) by overlaying blood on Ficollpaque plus (GE Healthcare), the serially diluted (300 U/mL, 100 U/mL, 30 U/mL, 10 U/mL, 3 U/mL) Dornase alfa (Pulmozyme®, Roche, USA) and 420 g/mL MgSO 4 (Magnesium Sulphate 15% Onfarma, TR) were incubated with the PBMCs for 48hr in T cell medium (6% Human AB Serum and 1% Pen/Strep, Texmacs medium). Immune cell subtypes and their activation levels were determined by Miltenyi MACSQuant flow cytometry analysis using CD3-PE, CD19-PE.cy7, CD56-FITC, CD4-Viogreen, CD8-Vioblue, CD25-APC and CD107a-PE.cy5.5 (Miltenyi).
+ Open protocol
+ Expand
8

Dornase alfa and MgSO4 Effects on PBMC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Three healthy adult blood was obtained from Acibadem Labcell Cellular Therapy Laboratory.
Following the isolation of peripheral mononuclear cells (PBMC) by overlaying blood on Ficollpaque plus (GE Healthcare), the serially diluted (300 U/mL, 100 U/mL, 30 U/mL, 10 U/mL, 3 U/mL) Dornase alfa (Pulmozyme®, Roche, USA) and 420 g/mL MgSO 4 (Magnesium Sulphate 15% Onfarma, TR) were incubated with the PBMCs for 48hr in T cell medium (6% Human AB Serum and 1% Pen/Strep, Texmacs medium). Immune cell subtypes and their activation levels were determined by Miltenyi MACSQuant flow cytometry analysis using CD3-PE, CD19-PE.cy7, CD56-FITC, CD4-Viogreen, CD8-Vioblue, CD25-APC and CD107a-PE.cy5.5 (Miltenyi).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!